Related references
Note: Only part of the references are listed.Induction of Abscopal Anti-Tumor Immunity and Immunogenic Tumor Cell Death by Ionizing Irradiation - Implications for Cancer Therapies
B. Frey et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Nanoparticles for cancer therapy using magnetic forces
Rainer Tietze et al.
NANOMEDICINE (2012)
The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Recent Developments in Cancer Vaccines
Karolina Palucka et al.
JOURNAL OF IMMUNOLOGY (2011)
Nanomedicine
C. Alexiou et al.
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2010)
Minireview: Nanoparticles and the Immune System
Banu S. Zolnik et al.
ENDOCRINOLOGY (2010)
The effect of magnetic nanoparticles of Fe3O4 on immune function in normal ICR mice
Baoan Chen
International Journal of Nanomedicine (2010)
Mitoxantrone-Mediated Apoptotic B16-F1 Cells Induce Specific Anti-tumor Immune Response
Chunyu Cao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Investigating the Immunologic Effects of CoCr Nanoparticles
Bamikole Ogunwale et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2009)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Immunogenicity of anthracyclines: moving towards more personalized medicine
Lionel Apetoh et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
A high field gradient magnet for magnetic drug targeting
Christoph Alexiou et al.
IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY (2006)
Magnetic Drug Targeting - A new approach in locoregional tumortherapy with chemotherapeutic agents. Experimental animal studies
C Alexiou et al.
HNO (2005)
Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients
A Chan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Cancer anti-angiogenic therapy
K Shimizu et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)